Diagnosis and treatment of adenovirus infection in immunocompromised patients (Q38145327)

29 August 2017

title

Diagnosis and treatment of adenovirus infection in immunocompromised patients (English)

1 reference

29 August 2017

1 reference

Susanne Matthes-Martin

series ordinal

1

1 reference

29 August 2017

Heidrun Boztug

series ordinal

2

1 reference

29 August 2017

Thomas Lion

series ordinal

3

1 reference

29 August 2017

publication date

27 September 2013

1 reference

Expert Review of Anti-infective Therapy

29 August 2017

published in

1 reference

29 August 2017

volume

11

1 reference

29 August 2017

issue

10

1 reference

29 August 2017

page(s)

1017-1028

1 reference

Adenoviruses in immunocompromised hosts

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Detection of a broad range of human adenoviruses in respiratory tract samples using a sensitive multiplex real-time PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Clinical features, adenovirus types, and local production of inflammatory mediators in adenovirus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Identification of a nonstructural DNA-binding protein (DBP) as an antigen with diagnostic potential for human adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Viral attachment strategies: the many faces of adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Epidemiology of severe pediatric adenovirus lower respiratory tract infections in Manitoba, Canada, 1991-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

A myocarditis outbreak with fatal cases associated with adenovirus subgenera C among children from Havana City in 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Epidemiological investigation of two parallel gastroenteritis outbreaks in school settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Evaluation of polyhexamethylene biguanide (PHMB) as a disinfectant for adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Estimating the primary etiologic agents in recreational freshwaters impacted by human sources of faecal contamination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

An outbreak of adenovirus type 7 in a residential facility for severely disabled children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Two Adenovirus Serotype 3 Outbreaks Associated with Febrile Respiratory Disease and Pharyngoconjunctival Fever in Children under 15 Years of Age in Hangzhou, China, during 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Surveillance of Airborne Adenovirus and Mycoplasma pneumoniae in a Hospital Pediatric Department

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus infections in Bordeaux University Hospital 2008-2010: clinical and virological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Spectrum of antimicrobial activity and user acceptability of the hand disinfectant agent Sterillium Gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Quantification of adenovirus in the lower respiratory tract of patients without clinical adenovirus-related respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Identification of adenoviruses in specimens from high-risk pediatric stem cell transplant recipients and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Latent species C adenoviruses in human tonsil tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Noncytolytic control of viral infections by the innate and adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Enteric prevalence of adenovirus in human immunodeficiency virus seropositive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Prevalence of enteric viruses in human immunodeficiency virus seropositive patients in Venezuela.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Short-term in-vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Why newborn screening for severe combined immunodeficiency is essential: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus viraemia and dissemination unresponsive to antiviral therapy in advanced HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

A novel human adenovirus hexon protein of species D found in an AIDS patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

35-year-old HIV-positive woman with Basal forebrain mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus infections in pediatric small bowel transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus infection in pediatric small bowel transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

A surveillance study of adenovirus infection in adult solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Few but severe viral infections in children with cancer: a prospective RT-PCR and PCR-based 12-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Respiratory viral infections in children with leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Viral findings in adult hematological patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus pneumonia during induction therapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

A rare case of adenoviral fulminant hepatic necrosis after chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Risk factors for molecular detection of adenovirus in pediatric hematopoietic stem cell transplantation recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Quantitative temporal and spatial distribution of adenovirus type 2 correlates with disease manifestations and organ failure during disseminated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Platelet-adenovirus vs. inert particles interaction: effect on aggregation and the role of platelet membrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Laboratory approaches to the diagnosis of adenovirus infection depending on clinical manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Diagnostic value of quantitative PCR for adenovirus detection in stool samples as compared with antigen detection and cell culture in haematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Real-Time Qualitative PCR for 57 Human Adenovirus Types from Multiple Specimen Sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenoviral load diagnostics by quantitative polymerase chain reaction: techniques and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Comparison of in-house real-time quantitative PCR to the Adenovirus R-Gene kit for determination of adenovirus load in clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus infections in adult recipients of blood and marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Combinatorial targeting of 2 different steps in adenoviral DNA replication by herpes simplex virus thymidine kinase and artificial microRNA expression for the inhibition of virus multiplication in the presence of ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Antiadenovirus activities of several classes of nucleoside and nucleotide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Safety and tolerability of cidofovir in high-risk pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

How I treat adenovirus in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Selection of perforin expressing CD4+ adenovirus-specific T-cells with artificial antigen presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Rapid salvage treatment with virus-specific T cells for therapy-resistant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Emerging Infections: Adenovirus Infections in Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Viral infections of the central nervous system in Spain: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus-Specific CD4+ T Cell Clones Recognizing Endogenous Antigen Inhibit Viral Replication In Vitro through Cognate Interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

High Levels of Adenovirus DNA in Serum Correlate with Fatal Outcome of Adenovirus Infection in Children after Allogeneic Stem‐Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

High lethality of human adenovirus disease in adult allogeneic stem cell transplant recipients with high adenoviral blood load

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836964

10.1586/14787210.2013.836964

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference